Insulet | PODD - Ebit

Aktienkurs
156.55
Täglich Wechseln
1.94 1.25%
Monatlich
-18.60%
Jährlich
-51.76%
Q2 Prognose
144.50




Ebit Veränderung Datum
Abbott USD 1.85B 684M 2026-03
Align Technology USD 178.05M 46.66M 2026-03
AtriCure USD 526K 1.96M 2026-03
Avanos Medical USD 8.9M 15.87M 2026-03
Baxter International USD 66M 280.2M 2026-03
Becton, Dickinson and Co. USD 627M 36M 2026-03
Boston Scientific USD 1.05B 190M 2026-03
Cardinal Health USD 861M 98M 2026-03
Cooper Companies USD 212.8M 72.4M 2025-12
Dexcom USD 255.3M 67.7M 2026-03
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Globus Medical USD 164M 17.31M 2026-03
ICU Medical USD 26.09M 770K 2025-12
Insulet USD 122M 24.3M 2026-03
Integra LifeSciences USD 11.47M 54.54M 2026-03
J&J USD 6.62B 1.51B 2026-03
Masimo USD 77.4M 6.5M 2026-03
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 44.16M 10.04M 2026-03
Roche Holding CHF 9.56B 2.1B 2025-12
Solventum Corp USD 85M 20M 2026-03
Stryker USD 1.1B 867M 2026-03
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 37.03M 686K 2026-03
West Pharmaceutical Services USD 177.1M 14.6M 2026-03
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03